PNPLA3 and metabolic dysfunction-associated steatotic liver disease: These data are in line with results of cross-sectional studies in nonalcoholic fatty liver disease [33], and suggest that PNPLA3 I148M may promote fibrogenesis by directly altering hepatic stellate cells lipid metabolism and trans-activation [36].